Huaren Shengwu
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $16M
Investors
- 1
About Huaren Shengwu
, trading as Huaren Shengwu, is a biopharmaceutical company that provides biomacromolecule drugs. More than 80% of members of the core research team has master's degree. In 2018, the firm received the State High & Innovative Technology Companies Award. In 2022, the phase II clinical trial of Platelet-Derived Growth Factor (TPG) started.20 per share at HKEX, under the ticker "2396". The company focuses on the research of biomacromolecule drugs such as protein products, nucleic acid-based medicine, and new cancer therapeutics which include growth factors, enzymes, mRNA vaccines, etc. The company sets up many technology platforms, such as yeast expression platform, mRNA platform, and nanocapsule delivery system. The company's revenue is generated by providing biomacromolecule drugs.
Who invested in Huaren Shengwu
1 investor across 1 round
See all investors in Huaren Shengwu
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 25, 2021
Amount
$16M
Investors
Questions about Huaren Shengwu
Who invested in Huaren Shengwu?
Huaren Shengwu has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huaren Shengwu raised?
Huaren Shengwu has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Huaren Shengwu last raise money?
Huaren Shengwu's most recent round on record is a Series A, in Oct 2021.
What does Huaren Shengwu do?
, trading as Huaren Shengwu, is a biopharmaceutical company that provides biomacromolecule drugs.
Where is Huaren Shengwu headquartered?
Huaren Shengwu is headquartered in Qingdao, China.
Which VCs invest in companies like Huaren Shengwu?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Huaren Shengwu's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Huaren Shengwu? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.